RE: pfizer trial design10 Nov 2020 00:19
mumbo jumbo
More importantly there may have been more susceptible/Vulnerable individuals , elderly ,male , ethnicity, comorbidities etc within the placebo arm compared with the vaccine arm This we do not know the composition of each arm yet but seems like a big asked to compare like with like in a trial of 24.5 k individuals that why I think this information was released far too early But we will have to wait and see just hoping RM gives a reassurance RNS tomorrow !